AstraZeneca
small molecule inhibitor targeting blood vessels inflammation and fibrosis | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
38 of 86
Related slides by other companies
MindMed
Investor Presentation
November 2024
for gad phase study designs voyage panorama | MindMed
Kymera
Investor Day
December 2021
achieved degradation in monocytes at flow i | Kymera
Bausch+Lomb
Investor Conference
January 2023
date june | Bausch+Lomb
Theravance Biopharma
Investor Conference
November 2022
study disposition | Theravance Biopharma
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights